NAT10 and colorectal carcinoma: Collectively, our results demonstrate that 5-Fu-induced NAT10 downregulation and the subsequent regulation of ERRFI1 ac4C modification provide insights into NAT10’s role in CRC progression, potentially contributing to the development of improved CRC treatment strategies.